CCR2 and amyotrophic lateral sclerosis: Taken together, these findings suggest CCR2+ peripheral blood-borne macrophages clear abnormal proteins, at least in the early stage of the disease, contributing to disease protection in neurodegenerative disorders, such as ALS, caused by abnormal protein accumulation.